Financials
Financial year 2025
ORL.Dr.P .LEFEBVRE from Chaudfontaine, company number BE0844157148, closed financial year 2025 with a result of € 333,009 after tax. For that financial year ORL.Dr.P .LEFEBVRE recorded a gross margin of € 451,070 and equity of € 30,135. Compared with financial year 2024, the result moved from € 320,597 to € 333,009. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.
€ 30,135
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 333,009
▲ 4% vs 2024
Profit after tax over the fiscal year.
€ 282,660
▲ 39% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 333,000 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
Debts at end 2025
€ 44,075
Loans from banks and other lenders, long and short.
€ 2,835
▼ 14% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 319,620 | € 435,933 | € 431,776 | € 451,070 | ▲ 4% |
| Profit after taxes | € 220,517 | € 322,124 | € 320,597 | € 333,009 | ▲ 4% |
| Equity | € 29,906 | € 30,030 | € 30,127 | € 30,135 | |
| Total debts | € 263,453 | € 393,158 | € 334,699 | € 386,419 | ▲ 15% |
| Cash | € 194,113 | € 344,554 | € 203,309 | € 282,660 | ▲ 39% |
| Retained profit | € 15,646 | € 15,770 | € 15,867 | € 15,875 | |
| Dividend | € 220,000 | € 322,000 | € 320,500 | € 333,000 | ▲ 4% |
| Bank debt | € 10,881 | € 0 | € 0 | € 44,075 | |
| Balance sheet total | € 293,359 | € 423,188 | € 364,826 | € 416,554 | ▲ 14% |
Key figures of ORL.Dr.P .LEFEBVRE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ORL.Dr.P .LEFEBVRE?
What happened at ORL.Dr.P .LEFEBVRE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 333,009 (▲ 4% vs 2024). filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Liège. KBO
In short
From € 220,517 profit in 2022 to € 333,009 profit in 2025.
Paid € 402,775 in corporate taxes since 2022.
Best year ever: 2025, with € 333,009 profit.
Paid out € 1.2 million in dividends to the owners in total.
A new publication or filing at ORL.Dr.P .LEFEBVRE? We notify you, reason included.
Follow ORL.Dr.P .LEFEBVREDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind ORL.Dr.P .LEFEBVRE is Philippe LEFEBVRE. Philippe LEFEBVRE is also behind Fonds Léon Frédéricq pour la Promotion des Recherches médicales, fondamentales et cliniques, auprès du Centre HospitalierUniversitaire de Liège, DENDROGENIX and Bridge2Health.
Directors
According to the 2025 annual accounts
Philippe LEFEBVRE
Director
Also active at: Fonds Léon Frédéricq pour la Promotion des Recherches médicales, fondamentales et cliniques, auprès du Centre HospitalierUniversitaire de Liège, DENDROGENIX, Bridge2Health
Establishments
Establishment units
Physical locations of this company
au Trihay 13
4053 Chaudfontaine
Avenue de l'Hôpital -
4000 Liège
Active since 1 March 2012
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0844.157.148
- VAT number
- BE 0844.157.148
- Registered office
- au Trihay 13, 4053 Chaudfontaine
- Names & denominations
- ORL.Dr.P .LEFEBVRE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 March 2012
- Peppol
- Active · Active since 16 Dec 2025
- Activities · NACE
Activiteiten van medisch specialisten
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten